MCKEON BRIAN P has filed 85 insider transactions across 2 companies since February 2023.
Most recent transaction: a option exercise of 8013 shares of Alkermes plc. ($ALKS) on May 31, 2025.
Activity breakdown: 0 open-market purchases and 9 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2025 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | M | Ordinary Shares | 8013 | $0.00 | 45,793.0000 | 169,198,000 | 21.21% | 0.00% |
| May 31, 2025 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | M | Restricted Stock Unit Award | 8013 | $0.00 | 0.0000 | 169,198,000 | 100.00% | 0.00% |
| May 31, 2025 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | F | Ordinary Shares | 1924 | $30.61 | 43,869.0000 | 169,198,000 | 4.20% | 0.00% |
| May 21, 2025 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | A | Non Qualified Stock Option (Right to Buy) | 13474 | $0.00 | 13,474.0000 | 169,198,000 | 9999.99% | 0.01% |
| May 21, 2025 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | A | Restricted Stock Unit Award | 6142 | $0.00 | 6,142.0000 | 169,198,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 252 | $0.00 | 0.0000 | 83,246,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 303 | $0.00 | 303.0000 | 83,246,000 | 50.00% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 308 | $0.00 | 615.0000 | 83,246,000 | 33.37% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 299 | $0.00 | 894.0000 | 83,246,000 | 25.06% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 299 | $0.00 | 50,168.5926 | 83,246,000 | 0.60% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | F | Common Stock | 569 | $444.53 | 49,599.5926 | 83,246,000 | 1.13% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 252 | $0.00 | 49,258.5926 | 83,246,000 | 0.51% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 303 | $0.00 | 49,561.5926 | 83,246,000 | 0.62% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 308 | $0.00 | 49,869.5926 | 83,246,000 | 0.62% | 0.00% |
| Aug. 5, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 192 | $0.00 | 0.0000 | 83,978,000 | 100.00% | 0.00% |
| Aug. 5, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | F | Common Stock | 117 | $455.08 | 48,981.5926 | 83,978,000 | 0.24% | 0.00% |
| Aug. 5, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 192 | $0.00 | 49,098.5926 | 83,978,000 | 0.39% | 0.00% |
| June 29, 2024 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | M | Ordinary Shares | 6104 | $0.00 | 39,245.0000 | 169,730,000 | 18.42% | 0.00% |
| June 29, 2024 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | M | Restricted Stock Unit Award | 6104 | $0.00 | 0.0000 | 169,730,000 | 100.00% | 0.00% |
| June 29, 2024 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | F | Ordinary Shares | 1465 | $24.10 | 37,780.0000 | 169,730,000 | 3.73% | 0.00% |
| May 31, 2024 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | A | Restricted Stock Unit Award | 8013 | $0.00 | 8,013.0000 | 169,730,000 | 9999.99% | 0.00% |
| May 31, 2024 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | A | Non Qualified Stock Option (Right to Buy) | 17492 | $0.00 | 17,492.0000 | 169,730,000 | 9999.99% | 0.01% |
| Feb. 15, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 483 | $206.94 | 48,884.5926 | 83,978,000 | 1.00% | 0.00% |
| Feb. 15, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Incentive Stock Option (right-to-buy) | 483 | $0.00 | 0.0000 | 83,978,000 | 100.00% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 432 | $0.00 | 0.0000 | 83,978,000 | 100.00% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 253 | $0.00 | 252.0000 | 83,978,000 | 50.10% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 435 | $0.00 | 48,202.5926 | 83,978,000 | 0.91% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 308 | $0.00 | 923.0000 | 83,978,000 | 25.02% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 303 | $0.00 | 606.0000 | 83,978,000 | 33.33% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 432 | $0.00 | 48,634.5926 | 83,978,000 | 0.90% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 253 | $0.00 | 48,887.5926 | 83,978,000 | 0.52% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 303 | $0.00 | 49,190.5926 | 83,978,000 | 0.62% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 308 | $0.00 | 49,498.5926 | 83,978,000 | 0.63% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | F | Common Stock | 1097 | $560.56 | 48,401.5926 | 83,978,000 | 2.22% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | A | Non-Qualified Stock Option (right-to-buy) | 5355 | $0.00 | 5,355.0000 | 83,978,000 | 9999.99% | 0.01% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | A | Incentive Stock Option (right-to-buy) | 178 | $0.00 | 178.0000 | 83,978,000 | 9999.99% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | A | Restricted Stock Unit | 1193 | $0.00 | 1,193.0000 | 83,978,000 | 9999.99% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 435 | $0.00 | 0.0000 | 83,978,000 | 100.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | J | Non Qualified Stock Option (Right to Buy) | 523 | $22.48 | 26,692.0000 | 163,742,000 | 2.00% | 0.00% |
| Feb. 10, 2024 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | M | Ordinary Shares | 4533 | $0.00 | 34,229.0000 | 169,730,000 | 15.26% | 0.00% |
| Feb. 10, 2024 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | F | Ordinary Shares | 1088 | $27.32 | 33,141.0000 | 169,730,000 | 3.18% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | J | Non Qualified Stock Option (Right to Buy) | 90 | $22.48 | 4,639.0000 | 163,742,000 | 1.98% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | J | Restricted Stock Unit Award | 88 | $0.00 | 4,533.0000 | 163,742,000 | 1.98% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | J | Non Qualified Stock Option (Right to Buy) | 313 | $24.24 | 15,990.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | J | Non Qualified Stock Option (Right to Buy) | 231 | $30.86 | 11,785.0000 | 163,742,000 | 2.00% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | J | Non Qualified Stock Option (Right to Buy) | 254 | $30.72 | 12,986.0000 | 163,742,000 | 1.99% | 0.00% |
| Nov. 17, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | J | Restricted Stock Unit Award | 119 | $0.00 | 6,104.0000 | 163,742,000 | 1.99% | 0.00% |
| Feb. 10, 2024 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | M | Restricted Stock Unit Award | 4533 | $0.00 | 0.0000 | 169,730,000 | 100.00% | 0.00% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | S | Common Stock | 615 | $563.82 | 70,478.5926 | 83,978,000 | 0.87% | 0.00% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 23326 | $141.60 | 71,093.5926 | 83,978,000 | 48.83% | 0.03% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Non-Qualified Stock Option (right-to-buy) | 23326 | $0.00 | 0.0000 | 83,978,000 | 100.00% | 0.03% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | S | Common Stock | 681 | $572.80 | 47,767.5926 | 83,978,000 | 1.41% | 0.00% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | S | Common Stock | 7128 | $571.84 | 48,448.5926 | 83,978,000 | 12.83% | 0.01% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | S | Common Stock | 5675 | $570.97 | 55,576.5926 | 83,978,000 | 9.27% | 0.01% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | S | Common Stock | 3912 | $569.91 | 61,251.5926 | 83,978,000 | 6.00% | 0.00% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | S | Common Stock | 1469 | $568.84 | 65,163.5926 | 83,978,000 | 2.20% | 0.00% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | S | Common Stock | 1564 | $567.35 | 66,632.5926 | 83,978,000 | 2.29% | 0.00% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | S | Common Stock | 701 | $566.53 | 68,196.5926 | 83,978,000 | 1.02% | 0.00% |
| Feb. 7, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | S | Common Stock | 1581 | $564.98 | 68,897.5926 | 83,978,000 | 2.24% | 0.00% |
| Aug. 5, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 192 | $0.00 | 47,859.3456 | 84,600,000 | 0.40% | 0.00% |
| Aug. 5, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | F | Common Stock | 117 | $504.08 | 47,742.3456 | 84,600,000 | 0.24% | 0.00% |
| Aug. 5, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Restricted Stock Unit | 192 | $0.00 | 3,704.0000 | 84,600,000 | 4.93% | 0.00% |
| July 7, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | F | Ordinary Shares | 1430 | $29.88 | 29,696.0000 | 163,742,000 | 4.59% | 0.00% |
| July 7, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | M | Ordinary Shares | 5957 | $0.00 | 31,126.0000 | 163,742,000 | 23.67% | 0.00% |
| July 7, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | M | Restricted Stock Unit Award | 5957 | $0.00 | 0.0000 | 163,742,000 | 100.00% | 0.00% |
| June 29, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | A | Restricted Stock Unit Award | 5985 | $0.00 | 5,985.0000 | 163,742,000 | 9999.99% | 0.00% |
| June 29, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | A | Non Qualified Stock Option (Right to Buy) | 12732 | $0.00 | 12,732.0000 | 163,742,000 | 9999.99% | 0.01% |
| May 5, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Common Stock | 560 | $178.26 | 47,655.3456 | 84,600,000 | 1.19% | 0.00% |
| May 5, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | EVP, CFO and Treasurer | M | Incentive Stock Option (right-to-buy) | 560 | $0.00 | 0.0000 | 84,600,000 | 100.00% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | M | Restricted Stock Unit | 303 | $0.00 | 3,896.0000 | 84,600,000 | 7.22% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | M | Restricted Stock Unit | 433 | $0.00 | 4,452.0000 | 84,600,000 | 8.86% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | M | Common Stock | 504 | $0.00 | 46,864.6426 | 84,600,000 | 1.09% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | M | Common Stock | 435 | $0.00 | 47,299.6426 | 84,600,000 | 0.93% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | M | Common Stock | 433 | $0.00 | 47,732.6426 | 84,600,000 | 0.92% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | M | Common Stock | 253 | $0.00 | 47,985.6426 | 84,600,000 | 0.53% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | M | Common Stock | 303 | $0.00 | 48,288.6426 | 84,600,000 | 0.63% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | F | Common Stock | 1208 | $503.65 | 47,080.6426 | 84,600,000 | 2.50% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | M | Restricted Stock Unit | 504 | $0.00 | 5,320.0000 | 84,600,000 | 8.65% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | M | Restricted Stock Unit | 435 | $0.00 | 4,885.0000 | 84,600,000 | 8.18% | 0.00% |
| Feb. 14, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | M | Restricted Stock Unit | 253 | $0.00 | 4,199.0000 | 84,600,000 | 5.68% | 0.00% |
| Feb. 8, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | A | Non-Qualified Stock Option (right-to-buy) | 8811 | $0.00 | 8,811.0000 | 84,600,000 | 9999.99% | 0.01% |
| Feb. 8, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | A | Restricted Stock Unit | 1231 | $0.00 | 5,824.0000 | 84,600,000 | 26.80% | 0.00% |
| Feb. 8, 2023 | IDEXX LABORATORIES INC /DE | $IDXX | MCKEON BRIAN P | Executive VP & CFO | A | Incentive Stock Option (right-to-buy) | 201 | $0.00 | 201.0000 | 84,600,000 | 9999.99% | 0.00% |
| Feb. 10, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | M | Ordinary Shares | 4445 | $0.00 | 25,169.0000 | 163,742,000 | 21.45% | 0.00% |
| Feb. 10, 2023 | Alkermes plc. | $ALKS | MCKEON BRIAN P | Director | M | Restricted Stock Unit Award | 4445 | $0.00 | 4,445.0000 | 163,742,000 | 50.00% | 0.00% |